Application of process capability indices to quality control in a clinical chemistry laboratory

Leslie Burnett, Gabe Hegedus, Doug Chesher, John Burnett, G Costaganna

Clinical Chemistry · 1996 · 10 citations · 9 references

DOIFull text

Open access

Abstract

concentration of scTnl (500 Mg/L), whereas cTnI was still not detectable. These results clearly indicate that subject 3 had no cardiac damage despitethe high valuesfor CK-MB and CK. In conclusion, the combined use of cTnI/scTnl assays appears suitable for providing clinicians in sports medicine new biological markers of high relevance and reliability for diagnosis of muscle injuries. ReK 1.. Clarkson PM. Ebbeling c. Investigation of serum creatine kinase variability after muscle-damaging exercise. din

References

9